RT @RichardPAConway: Dr Gossec et al. Multidomain indices show consistent benefit when applied to IL23i guselkumab COSMO
Tweet Content
Dr Gossec et al. Multidomain indices show consistent benefit when applied to IL23i guselkumab COSMOS trial. I like MDA (because its simple and so am I) so showing that. But same benefits seen in DAPSA, PASDAS, mCPDAI, GRACE, PsARC. @RheumNow #EULAR2022 POS1038 https://t.co/EU2VHpEGc3
Show on Archive Page
On
Display in Search Results
On
PDQ
Off